SE391927B - Analogiforfarande for framstellning av anthelmintiskt aktiva imidazo/4,5-f/kinolin-9-oler - Google Patents
Analogiforfarande for framstellning av anthelmintiskt aktiva imidazo/4,5-f/kinolin-9-olerInfo
- Publication number
- SE391927B SE391927B SE7405654A SE7405654A SE391927B SE 391927 B SE391927 B SE 391927B SE 7405654 A SE7405654 A SE 7405654A SE 7405654 A SE7405654 A SE 7405654A SE 391927 B SE391927 B SE 391927B
- Authority
- SE
- Sweden
- Prior art keywords
- oler
- quinolin
- preparation
- anthelmintic active
- analogical procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US367499A US3868378A (en) | 1973-06-06 | 1973-06-06 | Imidazo {8 4,5-f{9 {0 quinolin-9-ols |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7405654L SE7405654L (it) | 1974-12-09 |
| SE391927B true SE391927B (sv) | 1977-03-07 |
Family
ID=23447421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7405654A SE391927B (sv) | 1973-06-06 | 1974-04-26 | Analogiforfarande for framstellning av anthelmintiskt aktiva imidazo/4,5-f/kinolin-9-oler |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3868378A (it) |
| JP (1) | JPS5019776A (it) |
| BE (1) | BE816005A (it) |
| CH (1) | CH601295A5 (it) |
| DE (1) | DE2427411A1 (it) |
| DK (1) | DK133105C (it) |
| FR (1) | FR2232319B1 (it) |
| GB (1) | GB1409871A (it) |
| IL (1) | IL44283A (it) |
| NL (1) | NL7403667A (it) |
| SE (1) | SE391927B (it) |
| ZA (1) | ZA741268B (it) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5265325A (en) * | 1975-11-26 | 1977-05-30 | Kogyo Gijutsuin | Ball valve |
| FR2391214A1 (fr) * | 1977-05-20 | 1978-12-15 | Chauvin Blache Sa Labo | Nouveaux derives de l'indazole, leur procede de preparation et leur application en therapeutique |
| US4716168A (en) * | 1985-01-08 | 1987-12-29 | Norwich Eaton Pharmaceuticals, Inc. | Imidazo(4,5-f)quinolines useful as immunomodulating agents |
| EP1581217A4 (en) * | 2002-11-01 | 2007-07-11 | Merck & Co Inc | CARBONYLAMINO-BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF THE ANDROGEN RECEPTOR |
| WO2016083490A1 (en) * | 2014-11-27 | 2016-06-02 | Remynd Nv | Compounds for the treatment of amyloid-associated diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3517005A (en) * | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
| US3636216A (en) * | 1968-09-26 | 1972-01-18 | Salsbury Lab | Coccidiosis control with quinalinol derivatives |
| US3506667A (en) * | 1969-05-01 | 1970-04-14 | Warner Lambert Pharmaceutical | Furo quinoline carboxylates |
| CA942310A (en) * | 1969-07-09 | 1974-02-19 | Mitsuo Nakashita | Preparation of n-substituted 6,7-methylenedioxy-4-quinolone derivatives |
| GB1356937A (en) * | 1970-08-27 | 1974-06-19 | Wellcome Found | Pyrimido-isoquinolines |
| US3790576A (en) * | 1972-03-20 | 1974-02-05 | Parke Davis & Co | 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines |
-
1973
- 1973-06-06 US US367499A patent/US3868378A/en not_active Expired - Lifetime
-
1974
- 1974-02-25 IL IL44283A patent/IL44283A/en unknown
- 1974-02-26 ZA ZA00741268A patent/ZA741268B/xx unknown
- 1974-03-04 GB GB970774A patent/GB1409871A/en not_active Expired
- 1974-03-19 NL NL7403667A patent/NL7403667A/xx not_active Application Discontinuation
- 1974-04-26 SE SE7405654A patent/SE391927B/xx unknown
- 1974-06-04 JP JP49062612A patent/JPS5019776A/ja active Pending
- 1974-06-05 FR FR7419425A patent/FR2232319B1/fr not_active Expired
- 1974-06-06 DK DK302174A patent/DK133105C/da active
- 1974-06-06 BE BE145154A patent/BE816005A/xx unknown
- 1974-06-06 CH CH774174A patent/CH601295A5/xx not_active IP Right Cessation
- 1974-06-06 DE DE19742427411 patent/DE2427411A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| IL44283A (en) | 1976-12-31 |
| JPS5019776A (it) | 1975-03-01 |
| DK302174A (it) | 1975-02-03 |
| US3868378A (en) | 1975-02-25 |
| DK133105B (da) | 1976-03-22 |
| NL7403667A (it) | 1974-12-10 |
| GB1409871A (en) | 1975-10-15 |
| BE816005A (fr) | 1974-12-06 |
| IL44283A0 (en) | 1974-05-16 |
| FR2232319B1 (it) | 1978-03-24 |
| AU6910074A (en) | 1975-11-20 |
| DK133105C (da) | 1976-08-23 |
| FR2232319A1 (it) | 1975-01-03 |
| DE2427411A1 (de) | 1975-03-13 |
| ZA741268B (en) | 1975-09-24 |
| CH601295A5 (it) | 1978-07-14 |
| SE7405654L (it) | 1974-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO140301C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner | |
| NO741084L (no) | Fremgangsmåte til fremstilling av orale legemiddelpreparater. | |
| SE390819B (sv) | Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat | |
| NO138566C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater | |
| SE7710600L (sv) | Forfarande for framstellning av 1,3-bensoxazoler | |
| NO740606L (no) | Analogifremgangsmåte til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser. | |
| NO140496C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer | |
| NO141850C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. | |
| SE391926B (sv) | Analogiforfarande for framstellning av antibakteriellt aktiva 9-(substituerad amino)-imidazo/4,5-f/kinoliner | |
| NO139386C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive imidazopyridiner | |
| NO137550C (no) | Analogifremgangsmaate til fremstilling av anti-inflammatorisk virksomme 2,4,5-trisubstituerte oksazolforbindelser | |
| NO153806C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin. | |
| SE402009B (sv) | Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat | |
| SE409716B (sv) | Analogiforfarande for framstellning av 11beta-alkyl-delta4-estrener | |
| SE391927B (sv) | Analogiforfarande for framstellning av anthelmintiskt aktiva imidazo/4,5-f/kinolin-9-oler | |
| NO140860C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive triazolo-1,5-benzodiazepiner | |
| SE431451B (sv) | Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner | |
| NO139735C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimido(4,5-b)kinolin-4(3h)-on-derivater | |
| NO741939A (no) | Analogifremgangsmåte ved fremstilling av nye, terapeutisk aktive 3,4,5,6-tetrahydro(1,3)thiazolo(3,4-a)isokinolinderivater. | |
| NO740607L (no) | Analogifremgangsmåte til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser. | |
| SE420603B (sv) | Forfarande for framstellning av metyl-3-(2-kinoxolinylmetylen)-karbazat-n?721, n?724-dioxid | |
| NO140104C (no) | Analogifremgangsmaate til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet | |
| SE7700792L (sv) | Forfarande for framstellning av n,n'-diklor-isoftalsyraamid | |
| FI55664C (fi) | Foerfarande foer framstaellning av blodtryckssaenkande 5-oxo-2,3-dihydro-imidazo-(1,2-a)-s-triaziner | |
| IT998441B (it) | Procedimento per la preparazione di 3.3 tiobis 2 metossi i azaben zantrone |